1548 (1548) News
Track canonical SquawkNews coverage tagged to 1548, 1548. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Two Chinese pharma firms seek Hong Kong listings, incl. Salubris
Shenzhen Salubris Pharmaceuticals has applied for a Hong Kong listing, per an exchange filing. The sector is cited as the next wave of offerings in the city; no listing timeline details were provided.
EQUITY | Sep 04, 2026, 01:44 AM UTC
M
Genscript Biotech proposes spin-off and separate listing of Probio Technology
Genscript Biotech Corp proposes a spin-off and separate listing of Probio Technology.
EQUITY | Sep 04, 2026, 01:32 AM UTC
L
Genscript Biotech to keep controlling interest in ProBio after listing
Genscript Biotech says it will keep a controlling interest in ProBio after listing.
EQUITY | Sep 04, 2026, 12:30 AM UTC
L
Genscript ProBio spin-off details not yet finalized
Genscript says details of its ProBio spin-off are yet to be finalized.
EQUITY | Sep 04, 2026, 12:30 AM UTC
M
Genscript Biotech plans spin-off and Hong Kong listing of Probio
Genscript Biotech plans a spin-off and a Hong Kong listing of its non-wholly-owned subsidiary Probio Technology.
EQUITY | Sep 04, 2026, 12:28 AM UTC